Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 386

The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.

Molecular Subsets in the Gene Expression Signatures of Scleroderma Skin

Open access
Milano, Ausra, Pendergrass, Sarah A., Sargent, Jennifer L., George, Lacy K., McCalmont, Timothy H., Connolly, M. Kari, Whitfield, Michael L.·2008·PLoS ONE

Abstract

BACKGROUND: Scleroderma is a clinically heterogeneous disease with a complex phenotype. The disease is characterized by vascular dysfunction, tissue fibrosis, internal organ dysfunction, and immune dysfunction resulting in autoantibody production. METHODOLOGY AND FINDINGS: We analyzed the genome-wide patterns of gene expression with DNA microarrays in skin biopsies from distinct scleroderma subsets including 17 patients with systemic sclerosis (SSc) with diffuse scleroderma (dSSc), 7 patients with SSc with limited scleroderma (lSSc), 3 patients with morphea, and 6 healthy controls. 61 skin biopsies were analyzed in a total of 75 microarray hybridizations. Analysis by hierarchical clustering demonstrates nearly identical patterns of gene expression in 17 out of 22 of the forearm and back skin pairs of SSc patients. Using this property of the gene expression, we selected a set of 'intrinsic' genes and analyzed the inherent data-driven groupings. Distinct patterns of gene expression separate patients with dSSc from those with lSSc and both are easily distinguished from normal controls. Our data show three distinct patient groups among the patients with dSSc and two groups among patients with lSSc. Each group can be distinguished by unique gene expression signatures indicative of proliferating cells, immune infiltrates and a fibrotic program. The intrinsic groups are statistically significant (p<0.001) and each has been mapped to clinical covariates of modified Rodnan skin score, interstitial lung disease, gastrointestinal involvement, digital ulcers, Raynaud's phenomenon and disease duration. We report a 177-gene signature that is associated with severity of skin disease in dSSc. CONCLUSIONS AND SIGNIFICANCE: Genome-wide gene expression profiling of skin biopsies demonstrates that the heterogeneity in scleroderma can be measured quantitatively with DNA microarrays. The diversity in gene expression demonstrates multiple distinct gene expression programs in the skin of patients with scleroderma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0002696

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 80 references

Research works printed but not linked: 13

  1. MD Mayes, 1998, Classification and epidemiology of scleroderma., Semin Cutan Med Surg, 17, 22, 10.1016/S1085-5629(98)80058-8 · doi:10.1016/s1085-5629(98)80058-8
  2. VD Steen, 2000, Severe organ involvement in systemic sclerosis with diffuse scleroderma., Arthritis Rheum, 43, 2437, 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U · doi:10.1002/1529-0131(200011)43:11<2437::aid-anr10>3.0.co;2-u
  3. PJ Clements, 2000, Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial., Arthritis Rheum, 43, 2445, 10.1002/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q · doi:10.1002/1529-0131(200011)43:11<2445::aid-anr11>3.0.co;2-q
  4. AJ Barnett, 1988, A survival study of patients with scleroderma diagnosed over 30 years (1953–1983): the value of a simple cutaneous classification in the early stages of the disease., J Rheumatol, 15, 276
  5. VD Steen, 2001, Improvement in skin thickening in systemic sclerosis associated with improved survival., Arthritis Rheum, 44, 2828, 10.1002/1529-0131(200112)44:12<2828::AID-ART470>3.0.CO;2-U · doi:10.1002/1529-0131(200112)44:12<2828::aid-art470>3.0.co;2-u
  6. BM Kraling, 1996, Transplantation of systemic sclerosis (SSc) skin grafts into severe combined immunodeficient mice: increased presence of SSc leukocytes in SSc skin grafts and autoantibody production following autologous leukocyte transfer., Pathobiology, 64, 99, 10.1159/000164015 · doi:10.1159/000164015
  7. VV Yurovsky, 1994, Expansion of selected V delta 1+ gamma delta T cells in systemic sclerosis patients., J Immunol, 153, 881, 10.4049/jimmunol.153.2.881 · doi:10.4049/jimmunol.153.2.881
  8. WA Sewell, 1989, The T lymphocyte CD2 antigen–genetic and functional studies., Transplant Proc, 21, 41
  9. MJ Smyth, 1995, Cloning and characterization of a novel NK cell-specific serine protease gene and its functional 5′-flanking sequences., Immunogenetics, 42, 101, 10.1007/BF00178584 · doi:10.1007/bf00178584
  10. R Fleischmajer, 1977, [3H]Thymidine labeling of dermal endothelial cells in scleroderma., J Invest Dermatol, 69, 379, 10.1111/1523-1747.ep12510308 · doi:10.1111/1523-1747.ep12510308
  11. SA Douglas, 2000, Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey., Br J Pharmacol, 131, 1262, 10.1038/sj.bjp.0703690 · doi:10.1038/sj.bjp.0703690
  12. P Grieco, 2005, Urotensin-II receptor ligands. From agonist to antagonist activity., J Med Chem, 48, 7290, 10.1021/jm058043j · doi:10.1021/jm058043j
  13. AA Margolin, 2005, CGHAnalyzer: a stand-alone software package for cancer genome analysis using array-based DNA copy number data., Bioinformatics, 21, 3308, 10.1093/bioinformatics/bti500 · doi:10.1093/bioinformatics/bti500

Cited by

See all 386

Metadata

Authors
Milano, A., Pendergrass, S. A., Sargent, J. L., George, L. K., McCalmont, T. H., Connolly, M. K., & Whitfield, M. L.
Venue
PLoS ONE
Published
2008-07-16
Volume
3
Issue
7
Pages
e2696
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2024866056
Cited by
386
References
80
FWCI
12.64
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular Subsets in the Gene Expression Signatures of Scleroderma Skin. https://app.cochat.ai/papers/10.1371/journal.pone.0002696
The paper
Milano, A., Pendergrass, S. A., Sargent, J. L., George, L. K., McCalmont, T. H., Connolly, M. K., & Whitfield, M. L. (2008). Molecular Subsets in the Gene Expression Signatures of Scleroderma Skin. PLoS ONE. https://doi.org/10.1371/journal.pone.0002696

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.